Navigation Links
Metoprolol Succinate Recalled: Brand Name Drug Scarce But Still Available at Low Cost from Other Countries, PharmacyChecker.com Announces
Date:1/30/2009

Due to recent recalls, many U.S. pharmacies are now out-of-stock of the popular beta-blocker metoprolol succinate. The original, brand name version, Toprol XL, is in very low supply. PharmacyChecker.com finds that consumers can obtain Toprol XL from licensed pharmacies in other countries -- and a much lower cost.

White Plains, NY (PRWEB) January 30, 2009 -- Consumers who use the beta-blocker Metoprolol Succinate ER are scrambling to find medication as a result of recalls by makers of two versions of the generic drug. ETHEX Corporation recalled all strengths of its version on Wednesday and Sandoz apparently issued recalls, although not widely announced, in September and November 2008. An authorized generic version by Par Pharmaceutical is apparently in very short supply. The original, brand name Toprol XL from AstraZeneca is also in short supply in the U.S. as a result of the lack of generics.

Potential problems with the generic versions had been reported by ConsumerLab.com in March of last year. The FDA subsequently issued a warning letter to Sandoz in August regarding manufacturing deficiencies. Deficiencies were also reported by ETHEX in December, which suspended manufacture.

Checking prices on the pharmacy comparison website PharmacyChecker.com shows that the most popular strength (50 mg) of the brand name product is available for approximately $0.47 to $0.70 per pill from licensed pharmacies in New Zealand, Singapore, and Turkey where it is sold under other names such as Betaloc CR. Prices in the U.S. for brand name Toprol XL are generally much higher -- $1 to $1.40 per pill. Toprol XL and generic forms are not sold in Canada, but some Canadian online pharmacies refer orders to licensed pharmacies in other countries. Generics are also available from abroad, although it is unclear if these may be affected by the recall of generics in the U.S. Prices can be checked on PharmacyChecker.com.

PharmacyChecker.com operates the largest independent verification service of U.S. and foreign online pharmacies and offers one of the largest, free, drug price comparison websites. It is privately held and has no ownership in or from companies that sell or distribute pharmacy products. The company also operates www.MedicareDrugPlans.com where seniors can compare, rate, and review Medicare Part D prescription drug plans. PharmacyChecker.com is affiliated with ConsumerLab.com.

###

Read the full story at http://www.prweb.com/releases/metoprolol-succinate/toprol/prweb1938784.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Metoprolol around the time of surgery increases the risk of death and stroke: POISE trial
2. 31M Pounds of Peanut Butter, Paste Recalled: Report
3. Meijer Announces Voluntary Recall for Some Meijer Brand Peanuts and Ice Cream Novelties Citing Possible Health Risk
4. Stop & Shop Issues a Voluntary Recall of Stop & Shop Brand Sundae Cones
5. eFoodSafety.com Engages IridiumGroup to Develop New Brand Identity to Match Future Company Direction
6. Security blankets: Materialism and death anxiety lead to brand loyalty
7. Hillenbrand, Inc. Announces Corrected First-Quarter Earnings Release and Conference Call Date
8. Hillenbrand, Inc. Announces First-Quarter Earnings Release Date and Conference Call
9. Grocery Manufacturers Association: National Brands of Jarred Peanut Butter Not Affected by PCA Recall, Many Food Products Unaffected by Peanut Corporation of America (PCA) Recall
10. Rapid Generic Erosion of Branded Agents, Including Market-Leading Viagra, Will Cause Sales of Erectile Dysfunction Drugs to Remain Flat Over the Next Decade
11. Kellogg Company Announces Voluntary Nationwide Recall of Austin(R) and Keebler(R) Branded Peanut Butter Sandwich Crackers and Select Snack-Size Packs of Famous Amos(R) and Keebler(R) Soft Batch Peanut Butter Cookies Because of Possible Health Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... BANGALORE , February 21, 2017 ... Appropriate Technology for Adoption by Plastic Industry  ... STEER, ... and functionalise materials in the fields of plastics, pharmaceuticals, ... collaboration with Merck KGaA, Darmstadt, Germany ...
(Date:2/21/2017)... 21, 2017 ... new imaging solution that connects Lexmark multifunction printers (MFPs) ... the world,s leading scanning and indexing software solutions for ... hospitals to use a Lexmark MFP at the point ... workflow, helping facilities reach HIMSS Stage 7 ...
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
Breaking Medicine Technology: